Advertisement

Topics

PTC and Roche report solid data for Spinraza rival

05:48 EDT 5 Jul 2017 | BioPharmaDive

The biotech and its big pharma partner reported promising preliminary data for their spinal muscular atrophy drug at a conference over the weekend.

Original Article: PTC and Roche report solid data for Spinraza rival

NEXT ARTICLE

More From BioPortfolio on "PTC and Roche report solid data for Spinraza rival"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...